Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study
Cognitive Risk Stratification Score bei mittelalten und älteren Erwachsenen mit Typ-2-Diabetes: eine Querschnittstudie
The Journal of Clinical Endocrinology & Metabolism · 16.09.2025 · 110 (10) · e3313-e3321
DOI: 10.1210/clinem/dgaf063 ↗Auf einen Blick
Bei 150 Patient:innen mit Typ-2-Diabetes wurde ein Risikoscore zur Vorhersage von kognitiver Beeinträchtigung entwickelt. Der Score zeigte eine gute Trennschärfe (AUC 0,802).
Fragestellung
Lässt sich mit einem neuen Risk-Stratification-Score das Risiko für kognitive Beeinträchtigung bei mittelalten und älteren Erwachsenen mit Typ-2-Diabetes schnell vorhersagen?
Methode
Querschnittstudie in einer Primärversorgungs-Poliklinik in Singapur von Juli 2023 bis Februar 2024; Convenience-Sampling; Validierung eines Risk Stratification Score.
Ergebnisse
Kognitive Beeinträchtigung lag bei 49,3 % (n = 74) vor. Der Score mit MoCA, diastolischem Blutdruck und Short Physical Performance Battery erreichte eine AUC von 0,802 (P < .001); Cutoff 0,3: Sensitivität 63,5 %, Spezifität 86,8 %.
Schlussfolgerung der Autor:innen
Der Score ist laut Autor:innen ein vielversprechendes Instrument zur schnellen Beurteilung des Risikos für kognitive Beeinträchtigung in der Primärversorgung.
Kernaussagen
- 49,3 % der 150 Patient:innen hatten eine kognitive Beeinträchtigung
- AUC des Scores: 0,802
- Cutoff 0,3 mit Sensitivität 63,5 % und Spezifität 86,8 %
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Querschnittstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 04.02.2025. Verfasst von Jinghua Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Centre for Translational Medicine, Singapore…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cognitive Dysfunction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, National University of Singapore.
Themen: Diabetes mellitus, Gerontologische Pflege
Abstract (Originalsprache)
Context
Cognitive impairment (CI) affects approximately 45% of middle-aged and older adults with type 2 diabetes mellitus (T2DM) globally. Although formal comprehensive neuropsychological tests are the gold standard for diagnosing CI, they are often time-intensive and may not be feasible in primary care.
Objective
This study aimed to develop and validate a novel risk stratification score (RSS) to rapidly and comprehensively predict CI risk among middle-aged and older adults with T2DM, offering a streamlined alternative in clinical practice.
Methods
A cross-sectional study was conducted from July 2023 to February 2024 in a primary care polyclinic in Singapore's western region. Participants aged between 40 and 85 diagnosed with T2DM (n = 150) were included in a convenience sampling. The primary outcome was CI status, which was assessed using formal neuropsychological tests, including the Montreal Cognitive Assessment (MoCA).
Results
CI was identified in 49.3% of participants (n = 74). The RSS, incorporating the MoCA, diastolic blood pressure, and Short Physical Performance Battery, demonstrated excellent discrimination, achieving an area under the receiver operating characteristic curve of 0.802 (P < .001). With an optimal cutoff of 0.3, the model showed a sensitivity of 63.5% and specificity of 86.8%, effectively differentiating high- and low-risk CI groups.
Conclusion
RSS in clinical practice, exemplified by the Integrated Metabolic Cognitive Risk Stratification Pathway, is a promising tool for rapid CI risk assessment in primary care. Its robust predictive accuracy and ease of use support its application for early intervention in middle-aged and older adults with T2DM. Future studies should validate its use longitudinally and across diverse populations to enhance generalizability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Centre for Translational Medicine, Singapore 117599, Singapore.
- Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
- Immunology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore.
- Tokyo Medical and Dental University (TMDU), Graduate School of Medicine and Dentistry, Bunkyo City, Tokyo 113-8510, Japan.
- National Neuroscience Institute, Singapore 308433, Singapore.
- National University Polyclinics, National University Health System (NUHS), Singapore 609788, Singapore.
ORCID-Profile: Jinghua Zhang, Vivien Xi Wu
Förderung
- Japan Society for the Promotion of Science
- National University of Singapore
Zitieren
APA
Zhang, J., Tam, W. W. S., Lu, J., Chen, J., Kusuyama, J., Dong, Y., Yap, X. Y., Zhou, W., Wang, N., Yeo, H. N., Lee, F. J. S., & Wu, V. X. (2025). Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study. The Journal of Clinical Endocrinology & Metabolism, 110(10), e3313-e3321. https://doi.org/10.1210/clinem/dgaf063
Vancouver
Zhang J, Tam WWS, Lu J, Chen J, Kusuyama J, Dong Y, et al. Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study. The Journal of Clinical Endocrinology & Metabolism. 2025;110(10):e3313-e3321. doi:10.1210/clinem/dgaf063
BibTeX
@article{Zhang2025,
author = {Zhang, Jinghua and Tam, Wilson Wai San and Lu, Jinhua and Chen, Junjie and Kusuyama, Joji and Dong, Yanhong and Yap, Xin Yi and Zhou, Wentao and Wang, Na and Yeo, Hui Nan and Lee, Frena Jia Sy and Wu, Vivien Xi},
title = {Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {10},
pages = {e3313--e3321},
doi = {10.1210/clinem/dgaf063}
}
EUVIMED